Applied Therapeutics faces challenges after FDA rejection, but future opportunities exist. Learn why APLT stock could recover ...

Lexicon will move forward with no commercial sales team and no further promotional efforts for its Inpefa, a heart failure version of sotagliflozin approved by the FDA in 2023. The company will ...

Dev4All, 4P-Pharma's cutting-edge R&D booster, announces a strategic collaboration with Pharmaseed, an established Contract ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...

A clinical trial study will give vets medical and commercial-grade cannabis products to look at “real-world” use and its ...

However, an alternate approach leveraging both commercial and open-source software can mitigate risk, transform drug development, and accelerate time to market. To fully understand the potential ...

The Madras High Court has held that magic mushroom per se does not satisfy the requirement of a narcotic drug or a ...

A Sydney locksmith dealing drugs on the side has been locked up for his role in attempting to smuggle more than 6kg of ...

Patrick Smith, President of Drug Development Solutions, Certara. Inflation and the Covid-19 pandemic have put pharmaceutical ...

A southwest Sydney man, accused of supplying large amounts of cocaine, also allegedly broke into a woman’s home and raped her ...

Verastem's promising progress in RAS-driven cancers, potential FDA approval, and growth opportunities present a bullish ...